Expression of multidrug resistance-related genes (mdrl, MRP, GST-π and DNA topoisomerase II) in urothelial cancers

British Journal of Urology

Volumn 78, Issue 3, 1996, Pages 361-368

  Kim, W J ^a   Kakehi, Y ^a   Wu, W J ^a   Fukumoto, M ^a   Yoshida, O ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Gene expression; Multidrug resistance related genes; Urothelial cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BETA 2 MICROGLOBULIN; DNA TOPOISOMERASE (ATP HYDROLYSING); GLUTATHIONE TRANSFERASE; MESSENGER RNA;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; UROGENITAL TRACT CANCER;

DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION; GLUTATHIONE TRANSFERASE; HUMANS; UROLOGIC NEOPLASMS;

EID: 0030423146     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Young RC. Mechanisms to improve chemotherapy effectiveness. Cancer 1990; 65: 815-22
2. Farber E. Cellular biochemistry of the stepwise development of cancer with chemicals: GHA Clowes memorial lecture. Cancer Res 1984: 44: 5463-74
3. Fairchild CR, Ivy SP. Rushmore T. Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc Natl Acad Sel, USA 1987: 84: 7701-5
4. Thorgeirsson SS, Huber BE, Sorrell S, Fojo A, Pastan I, Gottesman MM. Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science 1987: 236: 1120-2
5. Solt D, Farber E. New principle for analysis of chemical carcinogenesis. Nature 1976; 263: 701-3
6. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67
7. Burt RK, Garfield S, Johnson K, Thorgeirsson SS. Transformation of rat liver epithelial cells with v-H-ras or v-raf causes expression of MDR1, glutathione-Stransferase-P and increased resistance to cytotoxic chemicals. Carcinogenesis 1988; 9: 2329-32
8. Weinstein RS, Jakate SM. Dominguez JM et al. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 1991; 51: 2720-6
9. Chin KV, Ueda K, Pastan I, Gottesman MM. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 1992; 255: 459-62
10. Bordow SB, Haber M. Madaflglio J, Cheung B. Marshall GM, Norris MD. Expression of the multidrug resistanceassociated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res 1994; 54: 5036-40
11. Volm M, Kastei M. Mattern J, Efferth T. Expression of resistance factors (P-glycoprotein, glutathione Stransferase-n, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas. Cancer 1993; 71: 3981-7
12. Mostofi FK, Sobin LH, Torloni H eds. Histological typing of urinary bladder tumours. In International Histological Classification of Tumours. No. 10. World Health Organization: Geneva, 1973
13. American Joint Committee on Cancer. Urinary bladder. In Manual for Staging of Cancer. Philadelphia. J.B. Lippincott, 1992: 195-200
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9
15. Kakehi Y, Wu W-J, Kirn W-J, Arao S. Fukumoto M, Yoshida 0. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers. Int J Urol 1995: 2: 309-15
16. Srimatkandada S. Medina WD, Cashmore AR et al. Amplification and organization of dihydrofolate reductase genes in a human leukemic cell line, K-562, resistant to methotrexate. Biochemistry 1983: 22: 5774-81
17. Horns RC Jr, Dower WJ, Schimke RT. Gene amplification in a leukemic patient treated with methotrexate. J Clin Oncol 1984: 2: 2-7
18. Dalton WS, Grogan TM, Meltzer PS et al Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 1989: 7: 415-24
19. Sonneveld P. Durie BG, Lokhorst HM et al. Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and HOVON. lancet 1992; 340: 255-9
20. Chan HS. Haddad G. Thorner PS et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 1991; 325: 1608-14
21. List AF, Spier C, Gréer J et al. Phase I/trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J Clin Oncol 1993; 11: 1652-60
22. Floyd JW, Lin CW. Prout GR Multi-drug resistance of a doxorubicin-resistant bladder cancer cell line. J Urol 1990; 144: 169-71
23. Shinohara N, Liebert M. Wedemeyer G, Chang JHC, Grossman HB. Evaluation of multiple drug resistance in human bladder cancer cell lines. J Urol 1993; 150: 505-9
24. Schneider J, Rubio MP, Barbazan MJ, Rodriguez-Escudero FJ, Scizinger BR, Castresana JS. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors. J Natl Cancer Inst 1994: 86: 850-5
25. Schneider E, Horton JK. Yang CH. Nakagawa M, Cowan KH. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 1994; 54: 152-8
26. De Jong S, Zijlstra JG, De Vries EGE. Mulder NH. Reduced DNA topoisomerase activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 1990; 50: 304-9
27. Batist G. Tulpule A, Sinha BK. Katki AG. Myers CE. Cowan KH. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 1986; 261: 1544-9
28. Kim W-J, Kakehi Y. Hirai M et al. Multidrug resistance-associated protein-mediated multidrug resistance modulated by cyclosporin A in a human bladder cancer cell line. Jpn J Cancer Res 1995; 86: 969-77
29. Noonan KE, Beck C, Holzmayer TA et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 7160-4
30. Murphy LD, Herzog CE, Rudick JB, Fojo AT, Bates SE. Use of the polymerase chain reaction in the quantification of mdr-1 gene expression. Biochemistry 1990; 29: 10351-6
31. Clifford SC, Thomas DJ, Neal DE, Lunée J. Increased mdrl gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay. Br J Cancer 1994; 69: 680-6
32. Doyle A, Martin WJ, Funa K et al. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med 1985; 161: 1135-51
33. Arao S, Suwa H, Mandai M et al. Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer. Cancer Res 1994; 54: 1355-9
34. Thomas DJ, Birch OJ, Vickers J et al. Glutathione-Stransferase rc expression in transitional cell carcinoma of the bladder. Br J Urol 1993; 72: 740-3
35. Zaman GJR, Lankelma J, van Tellingen 0 et al. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 1995; 92: 7690-4